Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RAMUCIRUMAB vs RAVULIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RAMUCIRUMAB vs RAVULIZUMAB: Safety Overview

Metric RAMUCIRUMAB RAVULIZUMAB
Total FAERS Reports 5,357 118
Deaths Reported 1,444 11
Death Rate 27.0% 9.3%
Hospitalizations 2,066 89
Average Patient Age 63.9 yrs 48.4 yrs
% Female Patients 33.0% 56.3%
Manufacturer Eli Lilly and Company Alexion Pharmaceuticals Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription N/A